Skip to main content
OrthoVellum
Orthopaedic Exam Prep
OrthoVellum
Orthopaedic Exam Prep

Exam-focused orthopaedic references, a question bank, viva practice, and spaced-repetition revision — with every clinical claim traceable to its source. Content is educational only and is not a substitute for local supervision, clinical judgement, or institutional policy.

Library

  • Clinical Topics
  • Blog
  • Site Updates
  • Content Methodology
  • Editorial Policy

Company

  • About Us
  • Authors & Disclosure
  • Editorial Policy
  • Editorial Board
  • Content Methodology
  • Advertising Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA

Support

  • Support OrthoVellum
  • Help Center
  • Accessibility
  • Report an Issue
Evidence. Clarity. Practice.

© 2026 OrthoVellum. For educational purposes only.

Not medical advice. Verify clinically important information against current local guidance.

Parsonage-Turner Syndrome

Back to Topics
Contents
0%

Parsonage-Turner Syndrome

Clinical overview of Parsonage-Turner Syndrome, including presentation, investigations, treatment principles, complications, and follow-up.

complete
Reviewed: 2026-06-07Maintained by OrthoVellum Medical Education Team
Peer-reviewed editorial processMethodologyReport a correction
High-yield overview

Neuralgic Amyotrophy | Severe Pain THEN Patchy Palsy | The Great Mimic

1 / 1000Annual incidence (primary care)
Pain firstThen weakness as pain fades
PatchyMultifocal, not one nerve
Two-thirdsResidual deficit at 3+ years

Two Forms

Idiopathic (INA)
PatternSporadic, single or few attacks, onset ~40 years
TreatmentPain control, early steroids, rehab
Hereditary (HNA)
PatternSEPT9 mutation, earlier onset, recurrent attacks
TreatmentSame acute care, genetic counselling
Classic phenotype
PatternUpper/middle trunk - long thoracic and suprascapular nerves
TreatmentObservation, scapular rehab

Critical Must-Knows

  • Pain BEFORE palsy: severe neuropathic shoulder/arm pain for days to weeks, then weakness emerges as pain settles
  • Patchy, multifocal: affects individual nerves or fascicles (long thoracic, suprascapular, AIN, PIN), not a single root or trunk
  • Immune-mediated: often triggered by infection, vaccination, surgery, or strenuous exercise
  • Hourglass fascicular constrictions: the structural lesion sits WITHIN the parent nerve, proximal to the branch point
  • Recovery is slow and often incomplete: two-thirds have residual pain or weakness at 3 years

Clinical Pearls

  • "
    Disproportionate early pain that wakes the patient is the giveaway
  • "
    Scapular winging plus a dropped shoulder = long thoracic plus suprascapular involvement
  • "
    It is the classic cause of 'spontaneous' AIN or PIN palsy
  • "
    No randomised evidence for any drug - steroids are used early on weak evidence

Clinical Imaging

Critical Parsonage-Turner Exam Points

Pain Comes First

Severe pain precedes weakness. A spontaneous upper-limb palsy with a preceding bout of disproportionate neuropathic pain is neuralgic amyotrophy until proven otherwise.

Patchy, Not Anatomical

Weakness does not respect a single nerve or root. A patchy pattern (for example winging PLUS deltoid weakness) points away from a compressive lesion and towards neuralgic amyotrophy.

The Great Mimic

It imitates rotator cuff tear, cervical radiculopathy, and isolated AIN/PIN palsy. Always ask about the painful onset to avoid an unnecessary cuff repair or discectomy.

Recovery Is Not Guaranteed

Do not promise full recovery. Around two-thirds have lasting pain, weakness, or fatigability at three years; counsel realistically.

Memory Aids

Overview and Epidemiology

Why Parsonage-Turner Matters

Neuralgic amyotrophy is the great mimic of the upper limb. Recognising the painful-onset, patchy palsy prevents misdiagnosis as a rotator cuff tear, cervical radiculopathy, or a simple compressive nerve entrapment - and prevents unnecessary surgery.

Parsonage-Turner syndrome (neuralgic amyotrophy, idiopathic brachial plexus neuritis) is an immune-mediated disorder of the brachial plexus and its branches. It is defined by attacks of severe neuropathic upper-limb pain followed by patchy, multifocal weakness and atrophy.

Demographics

  • Incidence: about 1 per 1,000 per year in primary care - far commoner than older textbooks state
  • Age: idiopathic form peaks around 40 years; hereditary form earlier (late 20s)
  • Sex: slight male predominance in idiopathic disease
  • Recurrence: roughly a quarter of idiopathic patients have further attacks over years

Long under-recognised; awareness is the main barrier to diagnosis.

Clinical Significance

  • Frequently misdiagnosed: mistaken for cuff pathology or radiculopathy
  • Classic cause of spontaneous AIN and PIN palsy
  • Slow recovery: months to years, often incomplete
  • Functional burden: residual pain, weakness, and fatigability are common

Early recognition allows pain control, rehabilitation, and realistic counselling.

According to PubMed, a prospective primary-care cohort found a one-year incidence of classic neuralgic amyotrophy of 1 per 1,000, suggesting the disorder is 30-50 times more common than previously thought (DOI).

Pathophysiology and Mechanisms

Where Is the Lesion?

In neuralgic amyotrophy the structural lesion is an intraneural hourglass-like fascicular constriction located WITHIN the parent nerve, proximal to the branch point - not external compression at the usual entrapment sites. This is why a "spontaneous AIN palsy" is really a proximal median-nerve fascicular problem.

Proposed mechanism (a "two-hit" model):

  1. Predisposition: a susceptible peripheral nervous system (clear in hereditary disease with SEPT9 mutations)
  2. Trigger: an immune-activating event - infection, vaccination, surgery, the peripartum period, or strenuous exercise
  3. Immune attack: focal inflammatory injury to specific nerves or fascicles within the brachial plexus
  4. Fascicular constriction: swelling, then incomplete and complete hourglass constriction, and finally fascicular entwinement - a continuum seen on high-resolution ultrasound

Pathology of the constricted segment:

  • Inflammatory cell infiltration
  • Demyelination
  • Reduction in the number of nerve fibres

Distribution:

  • Predilection for the upper and middle trunk - the long thoracic and suprascapular nerves are most often hit
  • Distal mononeuropathies (AIN, PIN, superficial radial) occur, but the lesion still sits proximally in the parent nerve
  • Phrenic nerve involvement can cause diaphragmatic palsy and breathlessness

Classification Systems

Idiopathic versus Hereditary Neuralgic Amyotrophy

FeatureIdiopathic (INA)Hereditary (HNA)
Onset ageAround 40 yearsYounger, late 20s
AttacksUsually single or fewRecurrent, more frequent
GeneticsSporadicSEPT9 mutation, autosomal dominant
Nerves outside plexusLess common (~17%)More common (~56%)
Functional outcomeBetter on averagePoorer, more severe paresis

The hereditary form is roughly ten times less common than the idiopathic form.

Pattern of Nerve Involvement

PatternTypical nervesClinical clue
Classic upper plexusLong thoracic, suprascapularWinging plus weak external rotation
Distal mononeuropathyAIN, PIN, superficial radialWeak OK sign or finger drop
Extra-plexalPhrenic, recurrent laryngealBreathlessness, hoarse voice
Diffuse/multifocalSeveral nerves at oncePatchy, asymmetric weakness

A patchy distribution that crosses nerve and root territories is the hallmark.

Clinical Assessment

History

  • Pain: sudden, severe, neuropathic shoulder/arm pain, often waking the patient
  • Sequence: pain for days to weeks, THEN weakness as pain eases
  • Triggers: ask about recent infection, vaccine, surgery, pregnancy, exertion
  • Sensory symptoms: present in most (around three-quarters) but milder than the pain
  • Family history: recurrent attacks suggest hereditary form

The painful prodrome is the single most useful historical clue.

Examination

  • Inspection: scapular winging, periscapular and deltoid wasting
  • Targeted motor testing: serratus anterior, supraspinatus/infraspinatus, FPL/FDP (AIN), finger extensors (PIN)
  • Patchy weakness: not confined to one nerve or root
  • Sensory exam: variable, often patchy sensory loss
  • Reflexes: usually preserved unless a major nerve is affected

Examine the whole upper limb - the deficit is rarely where the pain is worst.

Distinguishing Neuralgic Amyotrophy From Its Mimics

MimicShared featureKey difference
Cervical radiculopathyShoulder/arm pain plus weaknessRadiculopathy follows a dermatome/myotome; pain is neck-related and worse with neck movement
Rotator cuff tearPainful weak shoulderCuff tear has no patchy distal palsy and no severe neuropathic prodrome
Compressive AIN/PIN palsyIsolated distal motor palsyNeuralgic amyotrophy has a painful onset and proximal fascicular lesion
Acute calcific tendinitisSudden severe shoulder painNo motor palsy; calcium on radiograph

Red Flags to Exclude

Bilateral or rapidly ascending weakness, prominent sensory level, or bowel/bladder change should prompt consideration of Guillain-Barre syndrome, myelopathy, or a structural plexus lesion (tumour). Patchy painful upper-limb palsy with normal cord signs favours neuralgic amyotrophy.

Investigations

Investigation Protocol

ClinicalDiagnosis Is Clinical

History plus examination carry the diagnosis: a painful onset followed by patchy upper-limb weakness with a typical nerve distribution. Investigations support and localise rather than confirm.

2-4 WeeksElectrodiagnostics

EMG/NCS after about 2-3 weeks shows patchy denervation in the affected muscles with relatively preserved sensory studies in pure-motor branches. Helps map the multifocal pattern and excludes radiculopathy.

TargetedHigh-Resolution Ultrasound

HRUS of the clinically affected nerves can show nerve swelling, incomplete or complete constriction, and fascicular entwinement - a continuum that helps predict recovery versus need for surgery.

If UncertainMRI / MR Neurography

MRI shows muscle denervation oedema (bright T2 signal) and MR neurography can localise the fascicular lesion. Useful when the affected nerve is hard to pin down or to exclude a structural plexus lesion.

Bloods and triggers:

  • No specific blood test confirms the diagnosis
  • Consider testing for an antecedent trigger where relevant - hepatitis E serology is worthwhile, as acute hepatitis E virus infection has a recognised association with neuralgic amyotrophy

According to PubMed, a Swiss multicentre case-control study found a moderate association between concomitant acute hepatitis E virus infection and neuralgic amyotrophy, but not with Guillain-Barre syndrome or Bell's palsy (DOI).

Management Algorithm

Acute Phase (Pain Dominant)

Acute Management

Days 0-14Pain Control

Aggressive multimodal analgesia. Neuropathic agents (for example gabapentinoids, amitriptyline) plus simple analgesia; opioids may be needed short term. The early pain is severe and a major source of distress.

First MonthConsider Early Corticosteroids

Oral corticosteroids in the first month may shorten the painful phase and accelerate recovery in some patients, based on weak (non-randomised) evidence. Discuss the uncertainty and risks before starting.

EarlyProtect and Educate

Avoid overuse of the painful limb, protect from traction injury, and explain the natural history. Reassurance about the typical sequence (pain settles, then weakness emerges) reduces anxiety.

There is no proven disease-modifying drug; treatment is largely supportive.

Recovery Phase (Weakness Dominant)

Rehabilitation is the mainstay:

  • Scapular stabilisation and periscapular strengthening once pain allows
  • Avoid compensatory overload and glenohumeral stiffness
  • Pacing and energy conservation for fatigability
  • Address aberrant movement patterns (a structured neuromuscular programme helps)

Monitoring:

  • Serial clinical review for re-innervation
  • Repeat EMG at 3-6 months if recovery stalls
  • Re-image (HRUS / MR neurography) if a focal constriction is suspected and there is no recovery

Most spontaneous recovery occurs over months; counsel that it can take 1-3 years.

When to Consider Surgery

Indications:

  • A discrete hourglass fascicular constriction on imaging with no recovery
  • No clinical or electrical recovery by around 3-6 months
  • Severe, persistent isolated mononeuropathy (for example AIN/PIN) amenable to neurolysis

Procedures:

  • Interfascicular neurolysis for mild-moderate constriction
  • Resection and neurorrhaphy (or grafting) for severe constriction with loss of fascicle continuity
  • Tendon transfers as salvage for established, non-recovering deficits (for example for serratus anterior or finger extension)

Surgery targets the proximal intraneural lesion, not the classic distal entrapment site.

Complications and Sequelae

Long-Term Sequelae

SequelaFrequencyManagement
Residual weaknessCommon (up to two-thirds at 3 years)Rehabilitation, tendon transfer if fixed
Persistent/recurrent painCommonNeuropathic analgesia, pacing
Fatigability and reduced exercise toleranceFrequentEnergy conservation, graded activity
Scapular dyskinesis / wingingFrequent with long thoracic involvementScapular rehab, transfer if persistent
Recurrent attacks~25% idiopathic, higher hereditaryCounsel, treat each attack acutely
Diaphragmatic palsy (phrenic)UncommonMonitor; plication in selected cases

According to PubMed, a study of the clinical spectrum in 246 patients found that overall recovery is less favourable than usually assumed, with persisting pain and paresis in approximately two-thirds of patients followed for three years or more (DOI).

Clinical Relevance for the Orthopaedic Surgeon

The One That Gets Operated On By Mistake

The orthopaedic trap is operating on the wrong problem: a "frozen shoulder" or "cuff tear" that is actually neuralgic amyotrophy, or a "compressive AIN/PIN palsy" decompressed at the forearm when the lesion is a proximal fascicular constriction. The painful prodrome and patchy pattern are what save the patient an unnecessary operation.

Post-Surgical Neuralgic Amyotrophy

Neuralgic amyotrophy can occur after any surgery or anaesthetic, sometimes in a limb remote from the operation. New patchy painful weakness post-operatively is not always a positioning or block injury - keep neuralgic amyotrophy in the differential.

The Spontaneous AIN/PIN Palsy

Most spontaneous AIN and PIN palsies are now understood as forms of neuralgic amyotrophy with proximal fascicular constrictions. This reframes both diagnosis (image proximally) and surgery (operate proximally if at all).

Winging Scapula Workup

When serratus anterior winging follows a painful episode, neuralgic amyotrophy is the leading cause. Most recover; reserve nerve or tendon transfer for persistent, disabling winging after prolonged failure to recover.

Counselling

Set expectations early: pain settles first, strength returns slowly over months to years, and recovery may be incomplete. Honest counselling protects both patient and surgeon.

Evidence Base

Large Observational Cohort
van Alfen & van Engelen - Clinical Spectrum in 246 Cases
Key Findings:
  • 246 patients (199 idiopathic, 47 hereditary); pain runs in three phases with an initial severe phase lasting about 4 weeks
  • Sensory involvement in 78.4%; upper/middle trunk distribution (long thoracic and/or suprascapular) most common (71.1%)
  • Hereditary form: earlier onset, more attacks, more extra-plexal nerves, worse outcome than idiopathic
  • Persisting pain and paresis in about two-thirds of patients followed for 3+ years
Clinical Implication: Defines the classic phenotype and the sobering reality that recovery is slow and often incomplete - counsel accordingly.
Source: Brain 2006
Verify on PubMed (PMID 16371410)

Prospective Cohort
van Alfen et al. - Incidence in Primary Care
Key Findings:
  • Prospective primary-care registration of new neck/shoulder/arm complaints in 14,118 people over one year
  • 14 confirmed classic neuralgic amyotrophy cases, giving a one-year incidence of 1 per 1,000
  • Suggests the disorder is 30-50 times more common than previously believed
  • Under-recognition, not rarity, explains the historical low estimates
Clinical Implication: Neuralgic amyotrophy is common, not rare - it belongs near the top of the differential for any spontaneous painful upper-limb palsy.
Source: PLoS One 2015
Verify on PubMed (PMID 26016482)

Systematic Review
van Alfen, van Engelen & Hughes - Cochrane Review
Key Findings:
  • No randomised or quasi-randomised trials of any treatment for neuralgic amyotrophy were identified
  • Only anecdotal evidence available across 30 articles
  • One open-label retrospective series suggests oral prednisone in the first month may shorten initial pain and lead to earlier recovery in some patients
  • Randomised trials of corticosteroids and immune-modulating therapy are needed
Clinical Implication: There is no proven drug therapy; early corticosteroids are used on weak evidence, so treatment remains largely supportive and rehabilitation-focused.
Source: Cochrane Database Syst Rev 2009
Verify on PubMed (PMID 19588414)

Retrospective Case Series
Wang et al. - Hourglass-like Fascicular Constriction
Key Findings:
  • 20 patients (22 nerves) with spontaneous hourglass-like fascicular constriction in the upper limb
  • Acute pain always the first symptom, followed by rapid severe paralysis; constrictions unrelated to compressive structures
  • Histology: inflammatory infiltration, demyelination, and reduced nerve fibres
  • Early surgery recommended if no recovery by 3 months; neurolysis for mild-moderate, neurorrhaphy for severe lesions
Clinical Implication: Confirms an intraneural inflammatory lesion and supports targeted surgery (proximally) for non-recovering focal constrictions.
Source: J Neurosurg 2019
Verify on PubMed (PMID 30611131)

Review (Imaging Technique)
Cignetti et al. - Standardised Ultrasound Approach
Key Findings:
  • HRUS findings in neuralgic amyotrophy: nerve swelling, incomplete constriction, complete constriction, and fascicular entwinement - likely a continuum
  • These findings may help predict spontaneous recovery versus the need for surgery
  • For distal nerves (AIN, PIN, superficial radial), the lesion is almost always within the parent nerve, proximal to its branch point
  • History and examination should direct which nerves are scanned
Clinical Implication: HRUS localises the proximal intraneural lesion and stratifies which patients are likely to need surgery - changing both where you look and where you would operate.
Source: Muscle & Nerve 2022
Verify on PubMed (PMID 36040106)

Prospective Matched Case-Control
Ripellino et al. - Hepatitis E Virus and Neuralgic Amyotrophy
Key Findings:
  • Swiss multicentre case-control study over 3 years: 51 neuralgic amyotrophy, 59 Guillain-Barre, 70 Bell's palsy cases with matched controls
  • Six acute hepatitis E (IgM-positive) cases in the neuralgic amyotrophy group versus two in controls
  • Moderate association between acute hepatitis E virus infection and neuralgic amyotrophy only
  • Most cases with acute hepatitis E had raised liver enzymes at onset
Clinical Implication: Consider hepatitis E serology in acute neuralgic amyotrophy, especially with deranged liver enzymes - it identifies a recognised infective trigger.
Source: Eur J Neurol 2023
Verify on PubMed (PMID 37548584)

Exam Viva Scenarios

Use these scenarios to practise clinical reasoning and management decisions

CLINICAL SCENARIOStandard

Scenario 1: Painful Shoulder Then Winging

CLINICAL PROMPT

"A 38-year-old man develops sudden severe right shoulder pain that wakes him at night and lasts about two weeks. As the pain settles he notices his shoulder blade sticks out and he struggles to lift his arm overhead. He had a flu vaccine three weeks ago. What is your diagnosis and approach?"

PRACTICAL APPROACH
This is a classic presentation of Parsonage-Turner syndrome (neuralgic amyotrophy): severe neuropathic pain preceding patchy weakness, here with scapular winging from long thoracic nerve involvement, and a plausible immune trigger (recent vaccination). I would take a focused history of the pain-then-weakness sequence and triggers, then examine the whole upper limb for the patchy pattern - testing serratus anterior, supraspinatus and infraspinatus, and distal branches such as the AIN and PIN. The diagnosis is clinical. I would arrange EMG/NCS at around 2-3 weeks to map the multifocal denervation and exclude cervical radiculopathy, and consider high-resolution ultrasound of the affected nerves. Management is supportive: aggressive neuropathic pain control, consideration of early oral corticosteroids within the first month accepting the weak evidence, and scapular rehabilitation once pain allows. I would counsel that recovery is slow over months to years and may be incomplete, and that recurrence is possible.
KEY CLINICAL POINTS
Pain precedes patchy weakness - the diagnostic sequence
Scapular winging indicates long thoracic nerve involvement
Diagnosis is clinical; EMG/HRUS support and localise
Supportive care: analgesia, possible early steroids, scapular rehab
COMMON PITFALLS
Diagnosing a primary rotator cuff problem and missing the neuropathic prodrome
Promising rapid, full recovery
Forgetting to ask about triggers such as vaccination, infection, or surgery
FURTHER QUESTIONS
"Which nerves are most commonly affected in neuralgic amyotrophy?"
"What is the evidence for corticosteroids?"
CLINICAL SCENARIOChallenging

Scenario 2: The 'Spontaneous' AIN Palsy

CLINICAL PROMPT

"A 30-year-old woman presents with a weak OK sign and no sensory loss, preceded by a few days of forearm and arm pain. She has no history of trauma or mass. Imaging of the forearm is normal. How do you reconcile this with classic anterior interosseous syndrome, and what does it change?"

PRACTICAL APPROACH
Although this looks like anterior interosseous syndrome, the painful onset and absence of a compressive lesion strongly suggest this is a form of neuralgic amyotrophy presenting as an AIN palsy. The modern understanding is that most spontaneous AIN palsies are due to hourglass fascicular constrictions located within the median nerve proximal to the AIN branch point, not external entrapment in the forearm. This changes my approach in two ways. First, imaging: I would direct high-resolution ultrasound or MR neurography proximally, at and above the elbow, rather than focusing only on the forearm. Second, surgery: if intervention is needed for non-recovery, it should target the proximal intraneural constriction with interfascicular neurolysis, or resection and neurorrhaphy for severe constriction - a classic distal forearm decompression alone may miss the lesion. Initially I would manage supportively with analgesia and observation, as many recover, and reassess clinically and electrically over 3-6 months.
KEY CLINICAL POINTS
Painful spontaneous AIN palsy is usually neuralgic amyotrophy
The lesion is a proximal fascicular constriction, not forearm entrapment
Image and, if needed, operate proximally
Observe first; many recover spontaneously
COMMON PITFALLS
Performing a distal forearm decompression that misses the proximal lesion
Ignoring the painful prodrome that signals neuralgic amyotrophy
Rushing to surgery before allowing time for spontaneous recovery
FURTHER QUESTIONS
"Where do hourglass constrictions typically sit in a distal mononeuropathy?"
"What ultrasound findings would push you towards surgery?"
CLINICAL SCENARIOCritical

Scenario 3: No Recovery at Six Months

CLINICAL PROMPT

"A patient with confirmed neuralgic amyotrophy affecting the posterior interosseous nerve has had no clinical or electrical recovery at six months. High-resolution ultrasound shows a complete hourglass constriction of the affected fascicles. What are the options and how do you decide?"

PRACTICAL APPROACH
This is established neuralgic amyotrophy with a structural focal constriction and failed spontaneous recovery, which is the situation where surgery is justified. My options are interfascicular neurolysis, resection of the constricted segment with neurorrhaphy or grafting, and tendon transfers as a salvage. The choice depends on intraoperative findings and the severity of the constriction. For a mild-to-moderate constriction with preserved fascicular continuity, interfascicular neurolysis alone can be effective. For a severe complete constriction with loss of fascicle continuity, resection and direct neurorrhaphy, or grafting if there is a gap, gives the best chance. If the deficit is fixed and reconstruction is unlikely to succeed - for example with prolonged denervation and muscle atrophy - tendon transfers to restore finger and thumb extension are a reliable salvage. I would counsel that results after six months of denervation may be incomplete, and that the goal is functional improvement rather than guaranteed full recovery. I would also confirm the lesion location intraoperatively, expecting it proximal to the usual branch point.
KEY CLINICAL POINTS
No recovery plus a focal constriction is a surgical indication
Neurolysis for mild-moderate; resection/neurorrhaphy for severe
Tendon transfer is reliable salvage for fixed deficits
Counsel that recovery after prolonged denervation may be partial
COMMON PITFALLS
Continuing indefinite observation despite a structural lesion and no recovery
Choosing neurolysis alone for a severe complete constriction
Operating at the classic distal entrapment site rather than the proximal lesion
FURTHER QUESTIONS
"How do you decide between neurolysis and neurorrhaphy at operation?"
"What tendon transfers restore finger extension?"

MCQ Practice Points

The Diagnostic Sequence

Q: What is the characteristic temporal sequence of Parsonage-Turner syndrome? A: Severe neuropathic pain first, then patchy weakness as the pain subsides over days to weeks. This pain-before-palsy sequence is the key diagnostic clue.

Most Affected Nerves

Q: Which nerves are most commonly involved? A: The long thoracic and suprascapular nerves (upper/middle trunk distribution), involved in the majority of cases; distal branches such as the AIN and PIN are also classically affected.

The Structural Lesion

Q: What is the structural lesion in spontaneous distal mononeuropathies due to neuralgic amyotrophy? A: An hourglass-like fascicular constriction within the parent nerve, proximal to the branch point - not external entrapment at the usual distal site.

Drug Treatment Evidence

Q: What is the level of evidence for corticosteroids in neuralgic amyotrophy? A: Weak. A Cochrane review found no randomised trials; one open-label series suggested early oral prednisone may shorten initial pain and speed recovery in some patients.

Prognosis

Q: What proportion of patients have residual deficit at three years? A: About two-thirds have persisting pain or weakness at three years or more - recovery is slower and less complete than older teaching suggested.

Infective Trigger

Q: Which viral infection has a recognised association with neuralgic amyotrophy? A: Acute hepatitis E virus infection, particularly when accompanied by raised liver enzymes at onset.

Guidelines, Registries & Global Practice

Global Epidemiology:

  • Annual incidence around 1 per 1,000 in a prospective primary-care setting - far higher than older hospital-based estimates
  • Long under-recognised; awareness is the main determinant of diagnosis rate worldwide
  • Idiopathic form peaks around age 40; hereditary form (SEPT9) is roughly ten times less common with earlier, recurrent attacks
  • Recognised triggers (infection including hepatitis E, vaccination, surgery, peripartum period, exertion) are identified in roughly half of cases

Side-by-Side Practice (no condition-specific registry exists for neuralgic amyotrophy):

Body / SourceDiagnostic emphasisAcute treatmentImaging
Neuromuscular consensus (Cochrane-based)Clinical pain-then-palsy patternSupportive; early oral steroids on weak evidenceEMG to map multifocal denervation
Peripheral nerve / hand-surgery centresRecognise spontaneous AIN/PIN palsy as neuralgic amyotrophyObserve first; analgesiaHRUS / MR neurography to localise constriction
Rehabilitation servicesFunctional and patchy deficit mappingScapular and energy-conservation rehabClinical and serial EMG follow-up
Imaging-led unitsLocalise fascicular constrictionAs aboveHRUS continuum (swelling to entwinement) guides surgery

There is broad agreement that the diagnosis is clinical, that most cases are observed first with supportive care, and that imaging (HRUS / MR neurography) is increasingly used to localise a proximal fascicular constriction and select the minority who may benefit from surgery.

High- vs Limited-Resource Practice:

  • Well-resourced settings: HRUS and MR neurography localise intraneural constrictions; interfascicular microneurolysis and nerve reconstruction available for non-recovering focal lesions
  • Limited-resource settings: diagnosis is clinical (painful onset, patchy palsy, typical nerve distribution), often without electrodiagnostics or advanced imaging; management defaults to analgesia, rehabilitation, and observation, with tendon transfer as the principal salvage for established deficits

Documentation / Consent (universal):

  • Record the painful prodrome and the patchy, multifocal distribution that define the diagnosis
  • Counsel on slow, often incomplete recovery and the possibility of recurrence
  • For surgery on a fascicular constriction, consent should cover incomplete recovery and the need for possible nerve grafting or later tendon transfer
  • Document trigger screening, including hepatitis E serology where liver enzymes are deranged

PARSONAGE-TURNER SYNDROME

Clinical summary

Core Concept

  • •Immune-mediated neuralgic amyotrophy of the brachial plexus
  • •Pain FIRST, then patchy multifocal weakness and atrophy
  • •Lesion = hourglass fascicular constriction within the parent nerve
  • •Incidence about 1 per 1,000/year - common, not rare

Triggers

  • •Infection (including hepatitis E)
  • •Vaccination
  • •Surgery / anaesthesia
  • •Pregnancy/postpartum and strenuous exercise

Most Affected Nerves

  • •Long thoracic - scapular winging
  • •Suprascapular - weak external rotation
  • •Anterior interosseous - weak OK sign
  • •Posterior interosseous - finger drop

Diagnosis

  • •Clinical: painful onset plus patchy palsy
  • •EMG/NCS: multifocal denervation, maps pattern
  • •HRUS / MR neurography: localise constriction
  • •MRI: muscle denervation oedema (bright T2)

Management

  • •Aggressive neuropathic pain control
  • •Early oral corticosteroids (weak evidence)
  • •Scapular and energy-conservation rehabilitation
  • •Surgery only for non-recovering focal constriction

Prognosis

  • •Recovery slow: months to years
  • •Residual deficit in about two-thirds at 3 years
  • •Recurrence in ~25% idiopathic, higher hereditary
  • •Counsel realistically - do not promise full recovery
Editorially reviewed — transparent references and correction processPublished by OrthoVellum Medical Education TeamEditorial boardMethodologyReview policyReport a correction
Educational disclosure

Educational content is reviewed for source visibility, editorial coherence, and correction readiness.

No individual clinician credential is claimed unless a named person is shown.

Verify before clinical use; this is not medical advice or a substitute for local guidance.

Study Focus
Estimated read81 min

Decision sections

Related Topics

Anterior Interosseous Syndrome

Camptodactyly

Central Slip Injuries

Crystalline Arthropathy of the Hand